Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, and Charles River Laboratories (Charles River), a global industry-leading drug discovery, preclinical ...
Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...
Mice treated with the gene therapy remained cancer-free for at least 100 days and resisted cancer resurgence in a lab test.
The Cell & Gene Therapy manufacturing Services market is driven by increasing investments in advanced therapies, rising ...
It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.
GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...
Ocugen ($OCGN) is grabbing investors’ attention with its stock climbing 195% in the past year and its modifier gene therapy ...
Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...
The technique is called in vivo CAR-M therapy. "The nomination of the two autoimmune targets is a significant milestone in ...
There's new hope for people with sickle cell disease which affects mainly African Americans. It's gene therapy research at ...
GC Therapeutics, Inc. (GCTx), announced its launch today to scale and unlock the next generation of cell therapy. Invented and developed by a world-class team of scientists in the lab of professor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback